4//SEC Filing
Saad Kareem 4
Accession 0001415889-24-001671
CIK 0001818331other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:10 PM ET
Size
9.4 KB
Accession
0001415889-24-001671
Insider Transaction Report
Form 4
Saad Kareem
Chief Business Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-01-19+546→ 24,660 total - Exercise/Conversion
Restricted Stock Unit
2024-01-19−546→ 2,183 total→ Class A Common Stock (546 underlying) - Sale
Class A Common Stock
2024-01-22$3.24/sh−193$625→ 24,467 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.
- [F3]3/16th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on January 19, 2022, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on January 19, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873805
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:10 PM ET
- Size
- 9.4 KB